The global Linezolid market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Linezolid is an antibiotic drug that is used for the treatment of serious bacterial infections such as gram-positive bacteria, pneumonia, skin infections, and infections that are resistant to other antibiotics by stopping the growth of bacteria. This drug is either consumed by mouth or by injecting directly into the vein. The major factor for the growth of the market is the increasing prevalence of pneumonia. 

According to the World Health Organization (WHO), in 2019, pneumonia accounted for 14% of all children mortality with a mortality rate of 740,180 children under the age of five. Additionally, as per UNICEF 2021, the mortality rate due to pneumonia is more than 800,000 children under five every year or around 2,200 every day which includes over 153,000 newborns. Further, there are more than 1,400 cases of pneumonia per 100,000 children or 1 case per 71 children every year globally. Hence, the rising prevalence of pneumonia is increasing the risk for bacterial infections creating demand for linezolid. 

Some major players in the market include Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Alembic Pharmaceuticals Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in July 2017, HQ SPCLT PHARMA announced that their Linezolid intravenous solution 200MG/100ML (2MG/ML), 600MG/300ML (2MG/ML) was approved by the FDA. 

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered- 

o By Type

o By Application

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Alembic Pharmaceuticals Inc., among others.

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How players are addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Linezolid Market Report by Segment

By Type 

• Injection

• Tablets

By Application 

• Hospital Acquired Pneumonia (HAP)

• Community Acquired Pneumonia (CAP)

• Complex Skin Or Skin Soft Tissue Infection (SSTI)

• Vancomycin-Resistant Enterococcus (VRE) Infection

• Others

Global Linezolid Market Report by Region

North America

• United States

• Canada

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa